期刊文献+

强直性脊柱炎患者外周血调节性T淋巴细胞分析 被引量:5

Expression of regulatory T cells in the peripheral blood of patients with ankylosing spondylitis
原文传递
导出
摘要 目的探讨CD4+CD25high调节性T淋巴细胞在强直性脊柱炎(ankylosing spondylitis,AS)发生、发展中的意义。方法采用流式细胞术检测40例AS患者(AS组)和20例体检健康者(对照组)外周血CD4+CD25high调节性T淋巴细胞及人类白细胞抗原B27(human leucocyte antigen B27,HLA-B27)、血沉、C-反应蛋白水平,并进行比较。结果 HLAB27阳性AS组外周血CD4+CD25high调节性T淋巴细胞表达((11.41±3.69)%)明显高于对照组((8.78±2.84)%)(P<0.01)。AS组血沉((14.54±9.10)mm/h)及C-反应蛋白((6.51±4.18)mg/L)均高于对照组((8.55±5.56)mm/h和(3.39±2.32)mg/L)(P<0.01)。结论 HLA-B27阳性AS患者外周血CD4+CD25high调节性T淋巴细胞比率增高,并可能与AS疾病进程有关。 Objective To investigate the significance of CD4+ CD25^high regulatory T (Treg) cells in the development and progression of ankylosing spondylitis (AS). Methods The levels of CD4+ CD25^high Treg cells, human leucocyte antigen B27 (HLA-B27), erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) were determined by flow cytometry and were compared between 40 patients with AS and 20 healthy controls. Results The level of CD4+ CD25^high Treg cells was higher in positive-HLA-B27 AS patients ((11. 41±3. 69)%) than that in health controls ((8. 78±2.84)%) (P〈0.01). The levels of CRP and ESR were significantly higher in AS patients ((14. 54±9. 10)mm/h and (6.51±4. 18) rag/L) than those in health controls ((8. 55±5. 56)mm/h and (3. 39±2. 32) mg/L) (P〈0.01). Conclusion The proportion of CD4+ CD25^high regulatory T cells increases in positive-HLA-B27 AS patients, which might contribute to the development of AS.
作者 蔡春水 肖平
出处 《中华实用诊断与治疗杂志》 2013年第12期1192-1194,共3页 Journal of Chinese Practical Diagnosis and Therapy
基金 佛山市医学类科技攻关项目(201208027)
关键词 强直性脊柱炎 调节性T淋巴细胞 流式细胞术 Ankylosing spondylitis regulatory T cells flow cytometry
  • 相关文献

参考文献12

二级参考文献58

  • 1褚洪涛,张百安.云克与松梅乐治疗强直性脊柱炎疗效对比观察[J].中国误诊学杂志,2004,4(3):418-419. 被引量:19
  • 2沈玉光,许金良,杨宗林,赵婷茹.流式细胞术测肺癌患者外周血T细胞亚群及其与临床病理的关系[J].实用诊断与治疗杂志,2006,20(2):101-102. 被引量:22
  • 3陈丽娜,王聪华,朱平,樊春梅,王彦宏,李小燕.CD4^+CD25^(high)调节性T细胞在类风湿性关节炎病程中的消长及其意义[J].细胞与分子免疫学杂志,2007,23(4):331-334. 被引量:13
  • 4hevach EM,McHugh RS,Piccirilo CA,et al . Control of T-cell activation by CD4+CD25+Suppressor T cells [J] . Immunol Rev, 2001,182:58-67.
  • 5Dennis J, Hartigan-O' Cormor, Chungkee PoOh, Elizabeth Cinclair and Joseph M,McCune . Human CD4+ regulatory T cells express lower levers of the IL-7 receptor alpha chain (CD127),allowing consistent identification and sorting of live cells [J] . Janmal of Immunological methods, 2007,319(1-2) : 41-52.
  • 6Alison H . Cell-surface IL-7 receptor expression facilitates the purification of FOXP3+regulatory T cells [J] . Trend in Immunology, 2006,27(12):541-544.
  • 7Shevach EM,McHugh RS,Piccirilo CA,et al . Control of T-cell activation by CD4+CD25+ suppressor T cells [J] . Immunol Rev, 2001,182:58-67.
  • 8Sakaguchi S,Sakaguehi B,Shimizu J,et al. Immunlologic tolerance maintained by CD4+CD25+ regulatory T cells;their common role in controlling autoimmunity,rumor immunity,and transplantation tolerance [ J ] . Immunol Rev, 2001,182:18-32.
  • 9Crispin JC, Martinez A, Alocer-Varela J . Quantification of regulatory T cells in patients with systemic lupus erythematosus [J] . J Autoimmune, 2003,21 (3) : 273 -276.
  • 10Kukreja Cost G,Marker J,et al. Multiple immunoregulatory defects in type-diabetes[ J ] . J Clin Invest, 2002,109:131 ~ 140.

共引文献36

同被引文献34

  • 1陈顺乐,胡大伟,石学耕,沈南,顾越英,鲍春.The relationship between Th1/Th2-type cells and disease activity in patients with systemic lupus erythematosus[J].Chinese Medical Journal,2000(10):13-16. 被引量:27
  • 2赵丽珂,古洁若,余得恩.细胞因子对HLA-B27启动子的调节作用及其在强直性脊柱炎发病机制中的意义[J].中国病理生理杂志,2007,23(12):2455-2459. 被引量:5
  • 3Jia C, Liu H, Li M, et al. Effects of icariin on cytokine-induced ankylosing spondylitis with fibroblastie osteogenesis and its molecular mechanism[J]. Int J Clin Exp Pathol, 2014,7 (12) : 9104-9109.
  • 4Kang EH, Lee JT, Lee HJ, et al. Chronic periodontitis is associated with spinal dysmobility in patients with ankylosing spondylitis[J]. J Periodontol, 2015,20 : 1-15.
  • 5van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis: a proposal for modification of the New York criteria[J]. Arthritis Rheum, 1984,27(4) :361-368.
  • 6Nistri S, Grande-Allen J, Noale M, et al. Aortic elasticity and size in bicuspid aortic valve syndrome[J]. Eur Heart J, 2008,29 (4) :472-479.
  • 7Moyssakis I, Gialafos E, Vassiliou VA, et al. Myocardial performance and aortic elasticity are impaired in patients with ankylosing spondylitis[J]. Scand J Rheumatol, 2009,38 (3) : 216- 221.
  • 8Sundstrom B, Johansson G, Johansson I, et al. Modifiable cardiovascular risk factors in patients with ankylosing spondylitis [J]. Clin Rheumatol,2014,33(1) :111-117.
  • 9Gokmen F, Akbal A, Resorlu H, et al. Neutrophil lymphocyte ratio connected to treatment options and inflammation markers of ankylosing spondylitis[J]. J Clin Lab Anal,2015,29(4):294- 298.
  • 10Huang YP, Wang YH, Pan SL. Increased risk of ischemic heart disease in young patients with newly diagnosed ankylosing spondylitis: a population-based longitudinal follow-up study[J]. PLoS One,2013,8(5) :155-159.

引证文献5

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部